This HTML5 document contains 203 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34851156
rdf:type
wikibase:Item
schema:description
tieteellinen artikkeli artigo científico (publicado na 2013) ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ scientific article 2013年论文 2013年の論文 bilimsel makale article scientific 2013年論文 articolo scientifico 2013 թվականի հոտեմբերին հրատարակված գիտական հոդված บทความทางวิทยาศาสตร์ наукова стаття, опублікована в жовтні 2013 научни чланак article científic 2013年论文 2013年论文 tudományos cikk επιστημονικό άρθρο artikull shkencor 2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած научна статия 2013年論文 artículo científico publicado en 2013 2013年论文 artigo científico artigo científico (publicado na 2013) naučni članak мақолаи илмӣ 2013년 논문 vitskapeleg artikkel 2013年論文 artículu científicu espublizáu en 2013 vedecký článok bài báo khoa học wissenschaftlicher Artikel سائنسی مضمون wetenschappelijk artikel مقالة علمية vitenskapelig artikkel 2013年论文 teaduslik artikkel vědecký článek სამეცნიერო სტატია artikulong pang-agham scienca artikolo videnskabelig artikel (udgivet 2013) научная статья مقالهٔ علمی 2013 nî lūn-bûn 2013年论文 articol științific мақолаи илмӣ mokslinis straipsnis vetenskaplig artikel מאמר מדעי article scientifique (publié 2013) artykuł naukowy 2013年論文 научни чланак 2013年論文
p:P577
wds:Q34851156-20BF1673-0DE4-475E-9139-48905FDA12A4
wdt:P577
2013-10-04T00:00:00Z
p:P2860
wds:Q34851156-0F774B59-689E-4FB0-90B4-62C1CB679A88 wds:Q34851156-21C68F58-8C19-4393-B27F-E4552BD4D3EB wds:Q34851156-27B5E45D-1FDE-492B-B13F-0486F6D3A44A wds:Q34851156-1BDC0A56-1FAE-4D43-8E80-898095E42CE8 wds:Q34851156-8938CDAB-4A08-4014-9C13-5EE1A10B100E wds:Q34851156-738DD11E-0B6D-46E5-AD0D-6B9E954FB679 wds:Q34851156-7A26FCD5-9763-4460-AAF9-3D1A3E88689D wds:Q34851156-AE1DFA41-FA22-42E8-8E94-B2C1E9230D7B wds:Q34851156-AFD9A85A-D5DF-42EC-8C22-203222113A6E wds:Q34851156-B238C769-A94A-4828-B540-A2353724E33A wds:Q34851156-914B9527-F39E-405E-958B-C73DC57EA798 wds:Q34851156-46A45BED-9E5D-41CA-B359-918C5FC79FBE wds:Q34851156-2ED862E2-5896-4114-9D01-9F6959D3E406 wds:Q34851156-2FDC6736-C4B5-4CAC-A2F0-8C27D9B2D523 wds:Q34851156-5B41B560-00E9-4F3F-9052-4A0C98DB2455 wds:Q34851156-628F2EC0-7570-4130-BC49-F4C79D177190 wds:Q34851156-6A7E8ED2-B482-4BF3-A01B-FD4F9D63FEEB wds:Q34851156-56A33131-216B-40DA-A73D-1446DEFB279B wds:Q34851156-56F7AB23-F270-431D-8765-34F4C08B53B6 wds:Q34851156-59F54F27-2F94-4502-9503-8D8972CC61B2 wds:Q34851156-F11A502C-07D5-41CA-B363-EC6944DFEEB3 wds:Q34851156-F3A8798A-81DC-4097-80DE-4A7C0D50D768 wds:Q34851156-F9D3FE2F-D15C-4C88-AEE8-5703BE8FAFF2 wds:Q34851156-C2A6D5C4-6297-4C44-A73B-6A4B9718CD1D wds:Q34851156-C7B01B2D-6339-415F-8F6E-51E59AE7F914 wds:Q34851156-CB497D2E-201B-4439-AAAC-8DC2FD9BFDF7 wds:Q34851156-BFD26236-CDA9-46D0-9870-11256D17E1D9 wds:Q34851156-C163418C-78B6-43AA-B02E-8EF2DC545324 wds:Q34851156-DFF785A6-355B-415B-9603-229978BF6DCF wds:Q34851156-E5605B6F-5DD8-4DE3-816A-903469A37349 wds:Q34851156-ED0F7B42-45EF-4CED-8C2A-0EEDBEF2EBF8
wdt:P2860
wd:Q46685452 wd:Q46800161 wd:Q48001356 wd:Q27016629 wd:Q35770177 wd:Q34427979 wd:Q38155899 wd:Q46436937 wd:Q34310339 wd:Q48794915 wd:Q35966766 wd:Q40268444 wd:Q24561642 wd:Q46150147 wd:Q34287101 wd:Q34003196 wd:Q48627484 wd:Q33336619 wd:Q44020948 wd:Q36145437 wd:Q44194042 wd:Q27860595 wd:Q36458927 wd:Q37763502 wd:Q28362776 wd:Q28376841 wd:Q39842818 wd:Q36689936 wd:Q73308215 wd:Q35011885 wd:Q47845685
p:P2093
wds:Q34851156-08D36203-76E2-41F6-968C-036E0E7F0FBB wds:Q34851156-05F6F5C6-4D43-42CD-8082-3A7905363485 wds:Q34851156-1FDF54B4-5192-428E-A87D-4C9AE23CFD8E wds:Q34851156-16D5836A-6042-498C-821B-547958573DCA wds:Q34851156-23B33160-82CC-4EF4-96C3-F50D09793FDA wds:Q34851156-B60B2F4A-B52A-4071-8B5A-7FA7C8D06D45 wds:Q34851156-C58BC40E-372C-43FA-B196-06362CE738CC wds:Q34851156-D847BC7A-44ED-4BBB-B479-2DD92AF87A08 wds:Q34851156-DB8058A8-CD8E-4489-9B06-587ED2AF95F7 wds:Q34851156-F75EFCBA-D2C2-41D7-A1EB-DBE2618A07B6 wds:Q34851156-FE0F8911-5740-47E3-A6ED-3B8032FB29C8 wds:Q34851156-2F4B7532-7BCA-4C0D-8296-9A9629919F62 wds:Q34851156-324E5F6B-E08F-4E4B-8F51-05982C8DCF14 wds:Q34851156-5CCD8E9A-C4F2-45B0-B48A-CEC07CE1246B wds:Q34851156-82056FAC-77E0-4034-9277-A63D423F779A wds:Q34851156-855F8549-348D-432C-A65A-0FBDD1210005 wds:Q34851156-A664DC38-4242-48EE-A974-BBE159C10AF6 wds:Q34851156-9D58B6EC-44C5-431E-8F44-CCA279BC0E3A wds:Q34851156-B4560AF3-BD8A-41C6-8558-FBFC78A7296A
wdt:P2093
Christopher D Turner Federico Campigotto Donna S Neuberg Christine A Chordas Michael S Isakoff Shannon M Hubbs Susan N Chi Stewart Goldman Jay B Pietrantonio Laura Kondrat Mary Ann Zimmerman Anne E Bendel Ziad A Khatib Annette M Werger Wilbur J Pan Nathan J Robison Joshua B Rubin Melanie A Comito Peter E Manley
rdfs:label
A phase II trial of a multi-agent oral antiangiogenic A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer. A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer.
skos:prefLabel
A phase II trial of a multi-agent oral antiangiogenic A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer. A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer.
schema:name
A phase II trial of a multi-agent oral antiangiogenic A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer. A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer.
p:P50
wds:Q34851156-3F0D8DF8-D8CF-4ED5-BCCF-EE06D3271CEC wds:Q34851156-BA1A003D-5F93-42FC-AA70-645D478BCADB
wdt:P50
wd:Q39953868 wd:Q62097136
p:P1476
wds:Q34851156-6CE3136C-EDBA-48B4-8B3D-503F8FEFFB77
wdt:P1476
A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer
p:P304
wds:Q34851156-FE0271D3-1E9F-49E3-8E38-934A986A92EE
wdt:P304
636-642
p:P31
wds:Q34851156-E1A08F69-3EB2-43D5-B07C-3765359DFD42
wdt:P31
wd:Q13442814
p:P921
wds:Q34851156-2A8FD8E9-EBC0-41B0-9E3E-6DD9E4CC50A0 wds:Q34851156-43B38A60-B9B7-4F0C-8107-B5A447796057
wdt:P921
wd:Q574834 wd:Q42824440
p:P698
wds:Q34851156-7ED76C20-4A55-4506-A211-24314EA49B78
wdtn:P698
n9:24123865
wdt:P698
24123865
p:P1433
wds:Q34851156-D4C2D6A1-9A77-4513-BD7F-D0A3B4BA2848
wdt:P1433
wd:Q15754342
p:P433
wds:Q34851156-22A14115-8A67-4F5F-A56B-FE95EA94972E
p:P478
wds:Q34851156-8A87B564-94D6-4C98-B565-D397ECFBF37B
wdt:P433
4
wdt:P478
61
p:P356
wds:Q34851156-AD823FE1-D4D9-43A2-82B1-B7784F95793A
wdtn:P356
n8:PBC.24794
wdt:P356
10.1002/PBC.24794
p:P5875
wds:Q34851156-4F5C63BA-C69F-43B4-B4DE-93ED9A4868B6
wdt:P5875
257756266
p:P932
wds:Q34851156-CD76C9DE-0327-48AF-8977-9853152DF0CD
wdt:P932
4285784